|
IL138027A
(en)
*
|
1995-12-08 |
2004-08-31 |
Agouron Pharma |
Intermediates for the preparation and preparation of metalloproteinase inhibitors
|
|
US6500948B1
(en)
*
|
1995-12-08 |
2002-12-31 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof
|
|
US6747027B1
(en)
|
1996-07-22 |
2004-06-08 |
Pharmacia Corporation |
Thiol sulfonamide metalloprotease inhibitors
|
|
BR9710758A
(pt)
*
|
1996-07-22 |
1999-08-17 |
Monsanto Co |
Inibidores da metaloprotease de tiol sulfona
|
|
BR9712792A
(pt)
*
|
1996-08-28 |
1999-12-14 |
Procter & Gamble |
Inibidores de metaloprotease bidentada.
|
|
AU727820B2
(en)
*
|
1996-08-28 |
2000-12-21 |
Procter & Gamble Company, The |
1,3-diheterocyclic metalloprotease inhibitors
|
|
WO1998008827A1
(en)
*
|
1996-08-28 |
1998-03-05 |
The Procter & Gamble Company |
Heterocyclic metalloprotease inhibitors
|
|
RU2221782C2
(ru)
*
|
1996-08-28 |
2004-01-20 |
Дзе Проктер Энд Гэмбл Компани |
Замещенные циклические аминовые ингибиторы металлопротеаз
|
|
AU734834B2
(en)
|
1996-08-28 |
2001-06-21 |
Procter & Gamble Company, The |
Heterocyclic metalloprotease inhibitors
|
|
US6872742B2
(en)
|
1996-08-28 |
2005-03-29 |
The Procter & Gamble Company |
Substituted cyclic amine metalloprotease inhibitors
|
|
US6228869B1
(en)
|
1996-10-16 |
2001-05-08 |
American Cyanamid Company |
Ortho-sulfonamido bicyclic hydroxamic acids as matrix metalloproteinase and TACE inhibitors
|
|
US5929097A
(en)
*
|
1996-10-16 |
1999-07-27 |
American Cyanamid Company |
Preparation and use of ortho-sulfonamido aryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
|
|
US5962481A
(en)
*
|
1996-10-16 |
1999-10-05 |
American Cyanamid Company |
Preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
|
|
US5977408A
(en)
*
|
1996-10-16 |
1999-11-02 |
American Cyanamid Company |
Preparation and use of β-sulfonamido hydroxamic acids as matrix metalloproteinase and TACE inhibitors
|
|
DE69718038D1
(de)
*
|
1996-10-16 |
2003-01-30 |
American Cyanamid Co |
Herstellung und verwendung von ortho-sulfonamido-heteroarylhydroxamsäuren als matrix-metalloproteinase und tace inhibitoren
|
|
US6548524B2
(en)
|
1996-10-16 |
2003-04-15 |
American Cyanamid Company |
Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors
|
|
US6008243A
(en)
*
|
1996-10-24 |
1999-12-28 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them, and their use
|
|
US6174915B1
(en)
|
1997-03-25 |
2001-01-16 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
|
|
EP0948489A1
(en)
|
1996-12-17 |
1999-10-13 |
Fujisawa Pharmaceutical Co., Ltd. |
Piperazine compounds as inhibitors of mmp or tnf
|
|
US6696449B2
(en)
|
1997-03-04 |
2004-02-24 |
Pharmacia Corporation |
Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
|
|
US7115632B1
(en)
|
1999-05-12 |
2006-10-03 |
G. D. Searle & Co. |
Sulfonyl aryl or heteroaryl hydroxamic acid compounds
|
|
WO1998039326A1
(en)
|
1997-03-04 |
1998-09-11 |
Monsanto Company |
Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
|
|
DE69828783T2
(de)
*
|
1997-03-04 |
2006-01-12 |
Pharmacia Corp. |
Hydroxamsäure-sulfonamid-derivate mit amidiertem aromatischen ring
|
|
ES2209122T3
(es)
|
1997-03-04 |
2004-06-16 |
Pharmacia Corporation |
Compuestos de acido sulfonil alfa-hidroxi hidroxamico aromatico.
|
|
US6087359A
(en)
*
|
1997-03-04 |
2000-07-11 |
Getman; Daniel P. |
Thioaryl sulfonamide hydroxamic acid compounds
|
|
WO1998039316A1
(en)
|
1997-03-04 |
1998-09-11 |
Monsanto Company |
N-hydroxy 4-sulfonyl butanamide compounds
|
|
WO1998039315A1
(en)
|
1997-03-04 |
1998-09-11 |
Monsanto Company |
Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds
|
|
US6794511B2
(en)
|
1997-03-04 |
2004-09-21 |
G. D. Searle |
Sulfonyl aryl or heteroaryl hydroxamic acid compounds
|
|
US5985900A
(en)
*
|
1997-04-01 |
1999-11-16 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
|
|
CA2285372A1
(en)
*
|
1997-04-01 |
1998-10-08 |
Melwyn A. Abreo |
Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
|
|
WO1998050348A1
(en)
*
|
1997-05-09 |
1998-11-12 |
Agouron Pharmaceuticals, Inc. |
Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses
|
|
JP2004137284A
(ja)
*
|
1997-06-17 |
2004-05-13 |
Kaken Pharmaceut Co Ltd |
２−スルファモイル安息香酸誘導体
|
|
HUP0004595A3
(en)
|
1997-07-31 |
2001-12-28 |
Procter & Gamble |
Acyclic metalloprotease inhibitors
|
|
US6403632B1
(en)
*
|
2000-03-01 |
2002-06-11 |
Bristol Myers Squibb Pharma Co |
Lactam metalloprotease inhibitors
|
|
JPH11199512A
(ja)
*
|
1997-10-24 |
1999-07-27 |
Pfizer Prod Inc |
変形性関節症および他のｍｍｐ媒介疾患の治療のためのｍｍｐ−１３選択的阻害剤の使用
|
|
US6750228B1
(en)
|
1997-11-14 |
2004-06-15 |
Pharmacia Corporation |
Aromatic sulfone hydroxamic acid metalloprotease inhibitor
|
|
US20010039287A1
(en)
|
1997-11-14 |
2001-11-08 |
Thomas E Barta |
Aromatic sulfone hydroxamic acid metalloprotease inhibitor
|
|
JP2001523662A
(ja)
|
1997-11-14 |
2001-11-27 |
ジー・ディー・サール・アンド・カンパニー |
芳香族スルホンヒドロキサム酸メタロプロテアーゼ阻害剤
|
|
BR9907746A
(pt)
*
|
1998-01-27 |
2000-10-17 |
American Cyanamid Co |
ácidos 2,3,4,5-tetraidro-1h[1,4]-benzodiazepina-3-hidroxâmic os como inibidores de matriz de metaloproteinase
|
|
US6071903A
(en)
*
|
1998-01-27 |
2000-06-06 |
American Cyanamid Company |
2,3,4,5-tetrahydro-1H-[1,4]-benzodiazepine-3-hydroxyamic acids
|
|
US6410580B1
(en)
|
1998-02-04 |
2002-06-25 |
Novartis Ag |
Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
|
|
SK11692000A3
(sk)
|
1998-02-04 |
2001-02-12 |
Novartis Ag |
Sulfonylaminoderiváty, ktoré inhibujú metaloproteinázy degradujúce matricu, spôsob ich prípravy a farmaceutická kompozícia, ktorá ich obsahuje
|
|
US6329418B1
(en)
*
|
1998-04-14 |
2001-12-11 |
The Procter & Gamble Company |
Substituted pyrrolidine hydroxamate metalloprotease inhibitors
|
|
CN1301265A
(zh)
*
|
1998-05-14 |
2001-06-27 |
杜邦药品公司 |
新的用作金属蛋白酶抑制剂的取代的芳基异羟肟酸
|
|
EP1087937A1
(en)
|
1998-06-17 |
2001-04-04 |
Du Pont Pharmaceuticals Company |
Cyclic hydroxamic acids as metalloproteinase inhibitors
|
|
EP0965592A1
(en)
|
1998-06-18 |
1999-12-22 |
F. Hoffmann-La Roche Ag |
Process for preparing 3-arylsulfur hydroxamic acids
|
|
FR2780402B1
(fr)
*
|
1998-06-30 |
2001-04-27 |
Adir |
Nouveaux composes acides carboxyliques et hydroxamiques inhibiteurs de metalloproteases, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
UA59453C2
(uk)
*
|
1998-08-12 |
2003-09-15 |
Пфайзер Продактс Інк. |
Похідні гідроксипіпеколат гідроксамової кислоти як інгібітори матричних металопротеїназ
|
|
AU4925099A
(en)
*
|
1998-08-12 |
2000-03-06 |
Pfizer Products Inc. |
Tace inhibitors
|
|
US6509337B1
(en)
*
|
1998-09-17 |
2003-01-21 |
Pfizer Inc. |
Arylsulfonyl Hydroxamic Acid derivatives as MMP and TNF inhibitors
|
|
US6307049B1
(en)
|
1998-09-30 |
2001-10-23 |
The Procter & Gamble Co. |
Heterocyclic 2-substituted ketoamides
|
|
US6300341B1
(en)
|
1998-09-30 |
2001-10-09 |
The Procter & Gamble Co. |
2-substituted heterocyclic sulfonamides
|
|
CN1320028A
(zh)
*
|
1998-09-30 |
2001-10-31 |
宝洁公司 |
使用磺酰胺治疗脱发的方法
|
|
US6288261B1
(en)
*
|
1998-12-18 |
2001-09-11 |
Abbott Laboratories |
Inhibitors of matrix metalloproteinases
|
|
US6858598B1
(en)
*
|
1998-12-23 |
2005-02-22 |
G. D. Searle & Co. |
Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
|
AU783992B2
(en)
*
|
1998-12-23 |
2006-01-12 |
G.D. Searle Llc |
Method of using a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
|
US6326516B1
(en)
|
1999-01-27 |
2001-12-04 |
American Cyanamid Company |
Acetylenic β-sulfonamido and phosphinic acid amide hydroxamic acid TACE inhibitors
|
|
US6544984B1
(en)
|
1999-01-27 |
2003-04-08 |
American Cyanamid Company |
2,3,4,5-tetrahydro-1H-(1,4)benzodiazepine-3-hydroxamic acids
|
|
US6946473B2
(en)
|
1999-01-27 |
2005-09-20 |
Wyeth Holdings Corporation |
Preparation and use of acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as TACE inhibitors
|
|
US6762178B2
(en)
|
1999-01-27 |
2004-07-13 |
Wyeth Holdings Corporation |
Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
|
|
US6753337B2
(en)
|
1999-01-27 |
2004-06-22 |
Wyeth Holdings Corporation |
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors
|
|
AR022423A1
(es)
*
|
1999-01-27 |
2002-09-04 |
American Cyanamid Co |
Compuestos derivados de acidos 2,3,4,5-tetrahidro-1h-[1,4]benzodiazepina-3-hidroxamicos, composicion farmaceutica que los comprenden, y el uso de losmismos para la manufactura de un medicamento
|
|
US6225311B1
(en)
|
1999-01-27 |
2001-05-01 |
American Cyanamid Company |
Acetylenic α-amino acid-based sulfonamide hydroxamic acid tace inhibitors
|
|
CN1178915C
(zh)
|
1999-01-27 |
2004-12-08 |
惠氏控股有限公司 |
含有炔基的异羟肟酸衍生物、其制备及其作为基质金属蛋白酶抑制剂/TNF-α转变酶抑制剂的用途
|
|
US6200996B1
(en)
|
1999-01-27 |
2001-03-13 |
American Cyanamid Company |
Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
|
|
US6313123B1
(en)
|
1999-01-27 |
2001-11-06 |
American Cyanamid Company |
Acetylenic sulfonamide thiol tace inhibitors
|
|
US6277885B1
(en)
|
1999-01-27 |
2001-08-21 |
American Cyanamid Company |
Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid TACE inhibitors
|
|
US6340691B1
(en)
|
1999-01-27 |
2002-01-22 |
American Cyanamid Company |
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors
|
|
BR0008440A
(pt)
|
1999-02-08 |
2002-03-26 |
Searle & Co |
Inibidor de metaloprotease de sulfamato do ácido hidroxâmico
|
|
US6800646B1
(en)
|
1999-02-08 |
2004-10-05 |
Pharmacia Corporation |
Sulfamato hydroxamic acid metalloprotease inhibitor
|
|
RU2001126719A
(ru)
|
1999-03-03 |
2004-02-20 |
Дзе Проктер Энд Гэмбл Компани (US) |
Дигетерозамещенные ингибиторы металлопротеазы
|
|
JP2002538136A
(ja)
|
1999-03-03 |
2002-11-12 |
ザ プロクター アンド ギャンブル カンパニー |
アルケニルおよびアルキニル含有メタロプロテアーゼ阻害剤
|
|
AUPP982399A0
(en)
*
|
1999-04-19 |
1999-05-13 |
Fujisawa Pharmaceutical Co., Ltd. |
Mmp inhibitor
|
|
US6583299B1
(en)
|
1999-05-20 |
2003-06-24 |
G.D. Searle & Co. |
α-amino-β-sulfonyl hydroxamic acid compounds
|
|
US6869951B1
(en)
|
1999-07-16 |
2005-03-22 |
Pharmacia Corporation |
Method of changing conformation of a matrix metalloproteinase
|
|
PE20010659A1
(es)
|
1999-10-01 |
2001-06-20 |
Hoffmann La Roche |
Derivados de las pirimidin-2,4,6-trionas como inhibidores de metaloproteasas
|
|
CN1481377A
(zh)
|
2000-03-17 |
2004-03-10 |
����˹�ж�-����˹˹����ҩƷ��˾ |
作为基质金属蛋白酶和TNF-α的抑制剂的环β-氨基酸衍生物
|
|
IL151018A0
(en)
*
|
2000-03-17 |
2003-02-12 |
Bristol Myers Squibb Pharma Co |
Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha
|
|
EP1138680A1
(en)
*
|
2000-03-29 |
2001-10-04 |
Pfizer Products Inc. |
Gem substituted sulfonyl hydroxamic acids as MMP inhibitors
|
|
EP1208092B1
(en)
*
|
2000-04-07 |
2006-06-21 |
Samsung Electronics Co., Ltd. |
Sulfonamide derivative as a matrix metalloproteinase inhibitor
|
|
US6683093B2
(en)
|
2000-05-12 |
2004-01-27 |
Pharmacia Corporation |
Aromatic sulfone hydroxamic acids and their use as protease inhibitors
|
|
US6927216B2
(en)
|
2000-10-03 |
2005-08-09 |
Bristol-Myers Squibb Pharma Company |
Cyclic sulfonyl compounds as inhibitors of metalloproteases
|
|
AU2002246983A1
(en)
|
2001-01-11 |
2002-07-24 |
Bristol-Myers Squibb Pharma Company |
1,2-disubstituted cyclic inhibitors of matrix metallorproteases and tnf-alpha
|
|
CA2434205A1
(en)
|
2001-01-11 |
2002-07-18 |
Dupont Pharmaceuticals Company |
1,1-disubstituted cyclic inhibitors of matrix metalloprotease and tnf-.alpha.
|
|
FR2819252A1
(fr)
*
|
2001-01-11 |
2002-07-12 |
Servier Lab |
Nouveaux derives d'acide hydroxamique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
MXPA01013326A
(es)
|
2001-02-14 |
2002-08-26 |
Warner Lambert Co |
Bifenil sulfonamidas utiles como inhibisdores de metaloproteinasa de matriz.
|
|
US6720329B2
(en)
|
2001-03-15 |
2004-04-13 |
Bristol-Myers Squibb Pharma |
Spiro-cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α converting enzyme (TACE)
|
|
US6716845B2
(en)
|
2001-03-30 |
2004-04-06 |
Hoffmann-La Roche Inc. |
Barbituric acid derivatives
|
|
IL158454A0
(en)
|
2001-05-11 |
2004-05-12 |
Pharmacia Corp |
Aromatic sulfone hydroxamates and their use as protease inhibitors
|
|
WO2002096420A2
(en)
*
|
2001-05-29 |
2002-12-05 |
Guilford Pharmaceuticals Inc. |
Method for treating nerve injury caused by surgery
|
|
US6683078B2
(en)
|
2001-07-19 |
2004-01-27 |
Pharmacia Corporation |
Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors
|
|
AUPR726201A0
(en)
*
|
2001-08-24 |
2001-09-20 |
Fujisawa Pharmaceutical Co., Ltd. |
New use of a cyclic compound
|
|
JP2003081937A
(ja)
*
|
2001-09-07 |
2003-03-19 |
Bayer Ag |
ベンゼンスルホンアミド誘導体
|
|
CA2464727A1
(en)
|
2001-11-01 |
2003-05-08 |
Wyeth Holdings Corporation |
Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors
|
|
WO2003048119A2
(en)
*
|
2001-11-30 |
2003-06-12 |
Bristol-Myers Squibb Company |
Method of producing n-[(2s)-sulfanyl-4-(1,5,5-trimethylhydantoinyl)butanoyl]-l-leucyl-l-tert-leucine n-methylamide and intermediate thereof
|
|
PE20030701A1
(es)
|
2001-12-20 |
2003-08-21 |
Schering Corp |
Compuestos para el tratamiento de trastornos inflamatorios
|
|
MXPA04010555A
(es)
|
2002-04-25 |
2005-02-17 |
Pharmacia Corp |
Acidos piperidinil- y piperazinil-sulfonilmetil hidroxamicos y su uso como inhibidores de proteasa.
|
|
WO2003104224A1
(en)
|
2002-06-10 |
2003-12-18 |
Pfizer Inc. |
Metabolites of prinomastat and their sythesis
|
|
AU2003237532B2
(en)
*
|
2002-06-12 |
2009-07-30 |
Symphony Evolution, Inc. |
Human ADAM-10 inhibitors
|
|
AU2003277878A1
(en)
*
|
2002-06-25 |
2004-01-06 |
Pharmacia Corporation |
Arylsulfonylhydroxamic acid and amide derivatives and their use as protease inhibitors
|
|
AU2003304456A1
(en)
|
2002-12-23 |
2005-03-16 |
Wyeth Holdings Corporation |
Acetylenic aryl sulfonate hydroxamic acid tace and matrix metalloproteinase inhibitors
|
|
ATE429228T1
(de)
*
|
2003-02-14 |
2009-05-15 |
Serono Lab |
Derivate von piperazine-2-carboxamide
|
|
BRPI0407587A
(pt)
*
|
2003-02-18 |
2006-02-14 |
Pfizer |
inibidores do vìrus da hepatite c, composições e tratamentos que os utilizam
|
|
CN102146053A
(zh)
|
2003-03-24 |
2011-08-10 |
阿克西金药品公司 |
治疗哮喘及其它炎症或免疫性疾病的具有ccr3拮抗活性的2-苯氧基-和2-苯基磺酰胺衍生物
|
|
GT200500139A
(es)
|
2004-06-08 |
2005-07-25 |
|
Metodo para la preparacion de acidos hidroxamicos
|
|
US20100226922A1
(en)
*
|
2006-06-08 |
2010-09-09 |
Dorothea Maetzel |
Specific protease inhibitors and their use in cancer therapy
|
|
US8426415B2
(en)
|
2007-10-16 |
2013-04-23 |
Symphony Evolution, Inc. |
Human ADAM-10 inhibitors
|
|
EP2147684A1
(en)
*
|
2008-07-22 |
2010-01-27 |
Bracco Imaging S.p.A |
Diagnostic Agents Selective Against Metalloproteases
|
|
WO2011081884A1
(en)
|
2009-12-14 |
2011-07-07 |
Massachusetts Institute Of Technology |
Systems and methods related to optical nanosensors including photoluminescent nanostructures
|
|
IT1401253B1
(it)
|
2010-04-23 |
2013-07-18 |
Uni Degli Studi Carlo Bo Urbino |
Uso del sulodexide per la riduzione delle metalloproteinasi di matrice.
|
|
WO2013050476A1
(en)
*
|
2011-10-04 |
2013-04-11 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
New apoptosis inducing compounds
|
|
BR112021006407A8
(pt)
|
2018-10-04 |
2022-12-06 |
Inst Nat Sante Rech Med |
uso de inibidores do egfr para ceratodermas
|
|
JP7484901B2
(ja)
*
|
2019-04-26 |
2024-05-16 |
日産化学株式会社 |
アリールスルホン酸エステル化合物の製造方法
|
|
WO2020252439A1
(en)
*
|
2019-06-14 |
2020-12-17 |
Loyola University Of Chicago |
Carborane hydroxamic acid matrix metalloproteinase agents for boron neutron capture therapy
|